eptifibatide

基本解释

There is no apparent difference in early outcomes of patients treated with eptifibatide compared with patients treated with abciximab.
接受替非罗班治疗的患者的早期结果和接受阿昔单抗治疗的患者相比，不存在显著性差异。
Keywords acute coronary syndrome;myocardial infarction;platelet aggregation;eptifibatide;
急性冠脉综合征;心肌梗死;血小板聚集;依替巴肽;
Early initiation of eptifibatide in the emergency department before primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Results of the Time to Integrilin Therapy in Acute Myocardial Infarction(TITAN)-TIMI 34 trial
ST段抬高型心肌梗死患者行直接经皮冠状动脉介入术前依替巴肽的急诊早期使用:TITAN(急性心肌梗死患者中至应用依替巴肽治疗时间)-TIMI34试验的结果